THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN VOLEX PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.

LEI: 213800HBLQNH5FXXGE63
24 July 2026
Volex plc
("Volex" or the "Company")
Admission to trading on the Main Market of the London Stock Exchange and AIM Cancellation
Further to the announcement on 20 July 2026, Volex plc (LSE: VLX), the specialist integrated manufacturer of critical power and data transmission products, is pleased to announce that its ordinary shares (the "Ordinary Shares") will be admitted to the Equity Shares (Commercial Companies) Category of the Official List of the FCA and to trading on the Main Market of the London Stock Exchange at 8:00 a.m. today. Simultaneously, the Ordinary Shares will be cancelled from trading on AIM.
Volex is not offering any new Ordinary Shares nor any other securities in connection with Admission. Following Admission, the Company's Ordinary Shares will continue to be registered with their existing ISIN of GB0009390070 and the TIDM will remain VLX.
On Admission, the Company's issued ordinary share capital will be 184,377,640 Ordinary Shares. There are no Ordinary Shares held in treasury, and therefore the total voting rights in the Company is 184,377,640. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
The Company's shareholders should consult their own professional advisers regarding the consequences of Admission on their personal tax position.
Peel Hunt LLP is acting as Sponsor exclusively to the Company and no one else in connection with Admission.
Nat Rothschild, Volex's Chief Executive Officer, commented:
"Our move to the Main Market is a significant milestone for Volex, reflecting the growth in scale and performance we have delivered in recent years.
AIM has been a valuable platform for us, supporting Volex through a period of real transformation and sustained growth. This move aligns our listing with the size and ambition of the business today, and we believe it will broaden our appeal to a wider group of UK and international investors as we continue to execute our strategy and deliver on our targets.
I want to thank our customers, shareholders, and talented employees for their continued support along the way."
-ENDS-
For further information please contact:
|
Volex plc |
+44 (0) 1256 442570 |
|
|
Nat Rothschild, Chief Executive Officer |
investor.relations@volex.com |
|
|
Jon Boaden, Chief Financial Officer |
||
|
Peel Hunt LLP - Sponsor, Nominated Adviser & Joint Broker |
+44 (0) 20 7418 8900 |
|
|
Ed Allsopp |
||
|
Dom Convey |
||
|
Asha Chotai |
||
|
Tom Graham |
||
|
Jefferies - Joint Broker |
+44 (0) 20 7029 8000 |
|
|
Philip Noblet |
||
|
Sam Barnett |
||
|
Harry Le May |
||
|
Sodali & Co. - Media Enquiries |
+44 (0) 20 7250 1446 |
|
|
James White |
||
|
Pete Lambie |
Volex plc (LSE:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: EV & Electrification, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 23 advanced manufacturing facilities, uniting approximately 12,500 dynamic individuals across 25 countries. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.